UA37206C2 - Фармацевтична композиція, яка містить алкілсульфонамід-агоніст 5нті- подібного рецептора для ректального введення - Google Patents

Фармацевтична композиція, яка містить алкілсульфонамід-агоніст 5нті- подібного рецептора для ректального введення

Info

Publication number
UA37206C2
UA37206C2 UA94115989A UA94115989A UA37206C2 UA 37206 C2 UA37206 C2 UA 37206C2 UA 94115989 A UA94115989 A UA 94115989A UA 94115989 A UA94115989 A UA 94115989A UA 37206 C2 UA37206 C2 UA 37206C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
alkylsulfonamide
receptors
rectal administration
composition containing
Prior art date
Application number
UA94115989A
Other languages
English (en)
Russian (ru)
Inventor
Надін Мерлет
Надин Мерлет
Ізабель Річард
Изабелл Ричард
Ізабель Тілеманс
Изабелл Тилеманс
Original Assignee
Лаборатуар Глаксо Веллкам
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Глаксо Веллкам filed Critical Лаборатуар Глаксо Веллкам
Publication of UA37206C2 publication Critical patent/UA37206C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Фармацевтична композиція для ректального введення в твердій дозованій формі для лікування та/або попередження головного болю. Вона містить алкилсульфонамідну сполуку у формі вільної основи або її фізіологічно прийнятного сольвату і носій або наповнювач у вигляді твердої жирної основи. Винахід відноситься до фармацевтичної композиції, що містить як активний інгредієнт сполуку, яка є селективним антагоністом активності 5НТ1-подібних рецепторів.
UA94115989A 1992-05-07 1993-05-03 Фармацевтична композиція, яка містить алкілсульфонамід-агоніст 5нті- подібного рецептора для ректального введення UA37206C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (1)

Publication Number Publication Date
UA37206C2 true UA37206C2 (uk) 2001-05-15

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94115989A UA37206C2 (uk) 1992-05-07 1993-05-03 Фармацевтична композиція, яка містить алкілсульфонамід-агоніст 5нті- подібного рецептора для ректального введення

Country Status (33)

Country Link
US (1) US5705506A (uk)
EP (1) EP0639072B1 (uk)
JP (1) JPH07506570A (uk)
KR (1) KR100253111B1 (uk)
AT (1) ATE163850T1 (uk)
AU (1) AU670083B2 (uk)
BE (1) BE1007024A5 (uk)
BG (1) BG62120B1 (uk)
BR (1) BR1100108A (uk)
CA (1) CA2135179C (uk)
CH (1) CH685920A5 (uk)
CY (1) CY2039B1 (uk)
CZ (1) CZ283512B6 (uk)
DE (1) DE69317418T2 (uk)
ES (1) ES2113533T3 (uk)
FR (1) FR2690847B1 (uk)
GB (2) GB9209882D0 (uk)
GR (1) GR3026584T3 (uk)
HK (1) HK95697A (uk)
HU (2) HU227338B1 (uk)
IE (1) IE75203B1 (uk)
IL (1) IL105468A (uk)
IT (1) IT1261471B (uk)
NO (1) NO306700B1 (uk)
NZ (1) NZ252132A (uk)
OA (1) OA10109A (uk)
RO (1) RO112993B1 (uk)
RU (1) RU2118527C1 (uk)
SG (1) SG46649A1 (uk)
TW (1) TW231970B (uk)
UA (1) UA37206C2 (uk)
WO (1) WO1993021916A1 (uk)
ZA (1) ZA933178B (uk)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
AU749623B2 (en) * 1998-03-26 2002-06-27 Astellas Pharma Inc. Sustained release preparations
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
EP2451274B1 (en) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmaceutical compositions
CN103402514B (zh) 2010-10-15 2016-01-13 康特拉医药公司 用于治疗运动障碍的血清素受体激动剂组合物
MY169068A (en) 2012-04-18 2019-02-12 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
CN109689036B (zh) 2016-07-11 2026-06-19 康特拉医药股份有限公司 用于治疗早晨运动不能的脉冲药物输送系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
DK157995C (da) * 1980-08-12 1990-08-06 Glaxo Group Ltd Analogifremgangsmaade til fremstilling af indolderivater
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (uk) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
US4785016A (en) * 1984-12-04 1988-11-15 Glaxo Group Limited Indole derivatives
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
PH24976A (en) * 1987-08-13 1990-12-26 Glaxo Group Ltd Indole derivatives
CZ288351B6 (en) * 1990-06-07 2001-05-16 Astrazeneca Ab Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof

Also Published As

Publication number Publication date
HU211638A9 (en) 1995-12-28
NZ252132A (en) 1996-09-25
IL105468A (en) 1998-09-24
NO306700B1 (no) 1999-12-13
EP0639072B1 (en) 1998-03-11
GB2266665A (en) 1993-11-10
KR100253111B1 (en) 2000-07-01
ATE163850T1 (de) 1998-03-15
IE930339A1 (en) 1993-11-17
NO944214D0 (no) 1994-11-04
HK95697A (en) 1997-08-08
BE1007024A5 (fr) 1995-02-21
BG62120B1 (bg) 1999-03-31
FR2690847A1 (fr) 1993-11-12
OA10109A (en) 1996-12-18
BG99167A (bg) 1995-06-30
RO112993B1 (ro) 1998-03-30
RU2118527C1 (ru) 1998-09-10
ZA933178B (en) 1994-01-10
IE75203B1 (en) 1997-08-27
AU670083B2 (en) 1996-07-04
HUT71418A (en) 1995-11-28
BR1100108A (pt) 1999-12-07
IT1261471B (it) 1996-05-23
ES2113533T3 (es) 1998-05-01
FR2690847B1 (fr) 1995-06-09
ITRM930286A0 (it) 1993-05-06
JPH07506570A (ja) 1995-07-20
EP0639072A1 (en) 1995-02-22
CY2039B1 (en) 1998-04-30
GR3026584T3 (en) 1998-07-31
US5705506A (en) 1998-01-06
GB2266665B (en) 1996-05-22
AU4064093A (en) 1993-11-29
GB9309209D0 (en) 1993-06-16
DE69317418D1 (de) 1998-04-16
WO1993021916A1 (en) 1993-11-11
TW231970B (uk) 1994-10-11
CA2135179A1 (en) 1993-11-11
IL105468A0 (en) 1993-08-18
SG46649A1 (en) 1998-02-20
ITRM930286A1 (it) 1994-11-06
CH685920A5 (fr) 1995-11-15
GB9209882D0 (en) 1992-06-24
CZ283512B6 (cs) 1998-04-15
NO944214L (no) 1994-11-07
CA2135179C (en) 2000-12-05
DE69317418T2 (de) 1998-07-30
HU227338B1 (en) 2011-04-28
CZ272394A3 (en) 1995-10-18

Similar Documents

Publication Publication Date Title
YU49698A (sh) Smeše koje sadrže tetrahidrolipstatin
BG102254A (en) Oral fast soluble compositions as dopamine antagonists
ZA964735B (en) Compositions and methods for topical administration of pharmaceutically active agents
AU5159490A (en) Composition and method for administration of pharmaceutically active substances
MY115662A (en) Novel compounds with analgesic effect
LU91555I2 (fr) "Brinzolamide et timolol optionnellement sous de sels pharmaceutiquement acceptables te que la combination du produit brinzolamide/timolol maléate (AZARGA)"
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
CA2058428A1 (en) Analgesic formulations
NZ319531A (en) An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
HUP9903216A3 (en) Substituted benzamide and use of them as active ingredient in pharmaceutical compositions
HUT57203A (en) Process for substituted benzimidazol and paharmaceutical composition containing them
HU9503624D0 (en) Use of p antagonist in pharmaceutical compositions
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
MY115016A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
CA2135179A1 (en) Pharmaceutical Compositions of Alkylsulphonamides 5HT1 Agonists for Rectal Administration
YU242789A (en) New compound, 4-fluoro-2-//(4-metoxy-2-pyridin-yl)methylsulphinyl/-1h-benzimidazole and process for obtaining
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
HUT55402A (en) Process for producing glycosidase inhibitors and pharmaceutical compositions comprising such active ingredient
HUT53109A (en) Process for producing benzodiazepine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
HUT49590A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same as active ingredient
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
DK1030659T3 (da) Farmaceutisk præparat indeholdende (+)-efedrin og en H1-receptor antagonist
GB9211277D0 (en) Pharmaceutical compositions